Photobiomodulation Therapy in the Treatment of Salivary Dysfunction

Abueva, Celine

doi:10.25289/ml.2022.11.1.15

Cited by 9 publications

(8 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Photobiomodulation is performed by illuminating the tissues with low-level lasers (usually ranging from 0.05 to 0.5 W at the source) of a red light-wavelength ranging from 630 to 685 nm and an infrared-wavelength ranging from 780 to 970 nm [ 153 , 154 ]. Palma et al [ 130 ] evaluated the effect of photobiomodulation on the persistent xerostomia of head and neck cancer patients (n = 29, female: 27.6%, age: ≥37 years) receiving radiotherapy.…”

Section: Resultsmentioning

confidence: 99%

Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders

Tsuchiya

2023

Dentistry Journal

View full text Add to dashboard Cite

Since the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, treating taste and saliva secretory disorders associated with coronavirus disease 2019 (COVID-19) has become a critical issue. The aim of the present study was to update information on treatments applicable to such oral symptoms and discuss their pathogenic mechanisms. The literature search indicated that different treatments using tetracycline, corticosteroids, zinc, stellate ganglion block, phytochemical curcumin, traditional herbal medicine, nutraceutical vitamin D, photobiomodulation, antiviral drugs, malic acid sialagogue, chewing gum, acupuncture, and/or moxibustion have potential effects on COVID-19-associated ageusia/dysgeusia/hypogeusia and xerostomia/dry mouth/hyposalivation. These treatments have multiple modes of action on viral cellular entry and replication, cell proliferation and differentiation, immunity, and/or SARS-CoV-2 infection-induced pathological conditions such as inflammation, cytokine storm, pyroptosis, neuropathy, zinc dyshomeostasis, and dysautonomia. An understanding of currently available treatment options is required for dental professionals because they may treat patients who were infected with SARS-CoV-2 or who recovered from COVID-19, and become aware of their abnormal taste and salivary secretion. By doing so, dentists and dental hygienists could play a crucial role in managing COVID-19 oral symptoms and contribute to improving the oral health-related quality of life of the relevant patients.

show abstract

Section: Resultsmentioning

confidence: 99%

Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders

Tsuchiya

2023

Dentistry Journal

View full text Add to dashboard Cite

show abstract

“…It plays a crucial role in digestive, gustatory, phonation and teeth protection functions (Biology & 2018(Biology & , 2018 There are salivary parameters that must be in balance so that saliva functions are adequate. Salivary variations, such as decreased ow, change in pH and composition, can lead to changes in oral health, such as dry mucosa with consequent dysgeusia, dysphagia and dysphonia, or risk of developing ulcerations (Louzeiro et al, 2020) Phototherapy is a treatment with different modalities of light sources, such as laser, light emitting diode (LED) light, halogen light, or others (Abueva, 2022;Freitas et al, 2016. Photobiomodulation has been used in dentistry to relieve the side effects of cancer treatment, relieving pain, relieving the symptoms of Sjogren's Syndrome, reducing the amount of periodontal pathogenic bacteria, stimulating the salivary glands, increasing tissue regeneration undamaged glandular after cancer irradiation, improving saliva properties and acting on salivary rate in hyposalivation.…”

Section: Discussionmentioning

confidence: 99%

Preliminary Outcome of Immediate Effect of Photobiomodulation on PH and Salivary Flow

Fernandes,

Barros,

Santos

et al. 2023

Preprint

View full text Add to dashboard Cite

Objective Xerostomia, a common side effect of radiotherapy, can significantly impact patients' quality of life. This study aimed to compare the immediate effects of infrared light photobiomodulation on salivary flow and pH in individuals experiencing xerostomia. Twenty adults with xerostomia participated in the study, divided into two groups: Group 1 (G1) received extraoral photobiomodulation treatment, and Group 2 (G2) received both intra and extraoral treatment. Stimulated saliva was collected before and immediately after light application. In G1, the photobiomodulation was applied using a cluster with 3 spots (808 nm, 120 mW, 24J), while G2 received treatment with a pointer (808 nm, 100mW, 6J per point). The results confirmed our hypothesis, showing a statistically significant increase in immediate salivary flow stimulation with the headgear technique (G1) (p = 0.037). However, no significant change in salivary flow was observed in G2. Analyzing the percentage of volume variation (ml) per minute, the average salivary flow increased from 0.86 ml/min to 1.2 ml/min after extraoral application with an infrared laser cluster, representing a 7% increase. No significant change in pH was observed in either group. In conclusion, the protocol involving only extraoral application was effective in stimulating salivary flow, while the protocol combining intra and extraoral application did not yield the same results. Further research is needed to understand the specific mechanisms behind these differences and optimize photobiomodulation techniques for xerostomia management Clinical trial registration: NCT05413993 / 2022-06-10

show abstract

“…Photobiomodulation is performed by illuminating the tissues with low-level lasers (usually ranging from 0.05 to 0.5 W at the source) of a red light-wavelength ranging from 630 to 685 nm and an infrared-wavelength ranging from 780 to 970 nm [143,144]. Palma et al [145] evaluated the effect of photobiomodulation on persistent xerostomia of head and neck cancer patients (n = 29, female: 27.6%, age: ≥37 years) receiving radiotherapy.…”

Section: Photobiomodulation and Expected Outcomementioning

confidence: 99%

Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders

Tsuchiya¹

2023

Preprint

View full text Add to dashboard Cite

Since the worldwide spread of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), treating taste and saliva secretory disorders associated with coronavirus disease 2019 (COVID-19) has become one of the most critical issues in the COVID-19 era. The aim of the present study was to update information on treatments being applicable to such oral symptoms and discuss their pathogenic mechanisms. Promising treatments include different types of methods using tetracycline, corticosteroid, zinc, stellate ganglion block, phytochemical curcumin, traditional herbal medicine, nutraceutical vitamin D, photobiomodulation, antiviral drug, malic acid sialagogue, chewing gum, acupuncture, and/or moxibustion. At present, however, fully validated treatments are still lacking for COVID-19-associated ageusia/dysgeusia/hypogeusia and xerostomia/dry mouth/hyposalivation. An appropriately selected treatment and oral healthcare should be provided to COVID-19 patients and survivors suffering from taste and saliva secretory disorders. Understanding of currently available treatment options is required for dental profes-sionals because they not only experience patients who were infected with SARS-CoV-2 or recov-ered from COVID-19 but first become aware of their abnormal taste and salivary secretion. By doing so, dentists and dental hygienists can play a crucial role in managing COVID-19-associated oral symptoms and contribute to improving the oral health-related quality of life of the relevant dental patients.

show abstract

Photobiomodulation Therapy in the Treatment of Salivary Dysfunction

Cited by 9 publications

References 34 publications

Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders

Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders

Preliminary Outcome of Immediate Effect of Photobiomodulation on PH and Salivary Flow

Treatments of COVID-19-Associated Taste and Saliva Secretory Disorders

Contact Info

Product

Resources

About